Tag: AVS
AVS completes US$36 million Series B financing ahead of IVL US commercial launch
Amplitude Vascular Systems (AVS) recently announced that it has completed a Series B round of financ...
AVS’s pulsatile IVL technology attracts an additional US$8.8 million to close US$28.8 million Series B round
AVS, an early-stage medical device company focused on safely and effectively treating severely c...
Funding secured to advance development of Pulse IVL system
AVS has announced that it raised US$20 million in Series B financing, which the company says will ac...
